ABERRANT CELL-CYCLE INHIBITION PATTERN IN HUMAN COLON-CARCINOMA CELL-LINES AFTER EXPOSURE TO 5-FLUOROURACIL

被引:40
作者
PIZZORNO, G [1 ]
SUN, Z [1 ]
HANDSCHUMACHER, RE [1 ]
机构
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510
关键词
5-FLUOROURACIL; CELL LINES; COLON CARCINOMA; CELL CYCLE; FLOW CYTOMETRY; RNA POLYMERASE;
D O I
10.1016/0006-2952(94)00444-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this report, we describe the use of two human colon carcinoma cell lines, HCT-8 and HT-29, as potential models to study DNA- and RNA-directed cytotoxicity due to 5-fluorouracil (FUra) exposure by flow microfluorimetric analysis of DNA cell content. The sensitivity of the HT-29 line (EC(50) = 0.9 mu M) to FUra was somewhat greater than that of the HCT-8 line (EC(50) = 4 mu M) but each presented a dramatically different DNA histogram after exposure to FUra. In HCT-8, an unexpected and nearly complete disappearance of cells in S-phase occurred, whereas in HT-29 the expected accumulation of cells at the G(1)-S border was observed. The absence of HCT-8 cells in S-phase also occurred as a result of two RNA polymerase inhibitors: actinomycin D and dichloro-D-ribofuranosylbenzimidazole . However, an accumulation of cells in S-phase was observed in the presence of 5-fluorodeoxyuridine. These results suggest that in the HCT-8 cell line, FUra predominantly causes an RNA-related toxicity. By comparison, the rate of formation of 5-fluorodeoxyuridine monophosphate, the increased dUMP pool size, and low thymidylate synthase activity in the HT-29 line are consistent with its greater susceptibility to DNA-directed toxicity. Further evidence was seen in the prevention of FUra cytotoxicity by thymidine in HT-29, but not in HCT-8 cells. Similarly, Leucovorin synergized the action of FUra in HT-29 but not in HCT-8. Enzymatic correlates supporting these observations are seen in the greater activity of uridine kinase than thymidine kinase (20:1) in HCT-8 cells compared with that in HT-29 cells (4:1).
引用
收藏
页码:553 / 557
页数:5
相关论文
共 22 条
[1]  
BERGER SH, 1984, MOL PHARMACOL, V25, P303
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   USE OF PERIODATE AND METHYLAMINE FOR THE QUANTITATION OF INTRACELLULAR 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DREYER, R ;
CADMAN, E .
JOURNAL OF CHROMATOGRAPHY, 1981, 219 (02) :273-284
[4]  
GLAZER RI, 1982, MOL PHARMACOL, V21, P468
[5]   ELUCIDATION OF PATHWAYS OF 5-FLUOROURACIL METABOLISM IN XENOGRAFTS OF HUMAN COLORECTAL ADENOCARCINOMA [J].
HOUGHTON, JA ;
HOUGHTON, PJ .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (06) :807-815
[6]  
INGRAHAM HA, 1980, CANCER RES, V40, P998
[7]  
KUFE DW, 1981, J BIOL CHEM, V256, P9802
[8]  
KUFE DW, 1981, J BIOL CHEM, V256, P8885
[9]  
MARTIN DS, 1980, CANCER, V45, P1117, DOI 10.1002/1097-0142(19800315)45:5+<1117::AID-CNCR2820451316>3.0.CO
[10]  
2-S